{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T21:39:56Z","timestamp":1786743596920,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T00:00:00Z","timestamp":1713657600000},"content-version":"am","delay-in-days":660,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejmech.2022.114380","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T11:13:01Z","timestamp":1649848381000},"page":"114380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Structure-activity relationships of 1,4-bis(arylsulfonamido)-benzene or naphthalene-N,N\u2032-diacetic acids with varying C2-substituents as inhibitors of Keap1-Nrf2 protein-protein interaction"],"prefix":"10.1016","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2257-0798","authenticated-orcid":false,"given":"Sumi","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-9602","authenticated-orcid":false,"given":"Dhulfiqar Ali","family":"Abed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0936-2019","authenticated-orcid":false,"given":"Mai-Uyen","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4082-4330","authenticated-orcid":false,"given":"Michael P.","family":"Verzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1799-5652","authenticated-orcid":false,"given":"Longqin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114380_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of ageing","volume":"408","author":"Finkel","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114380_bib2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000485089","article-title":"Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species","volume":"44","author":"He","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2022.114380_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2022.114380_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2022.114380_bib5","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1073\/pnas.0307301101","article-title":"Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers","volume":"101","author":"Wakabayashi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2022.114380_bib6","doi-asserted-by":"crossref","first-page":"14960","DOI":"10.1073\/pnas.93.25.14960","article-title":"Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene","volume":"93","author":"Venugopal","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2022.114380_bib7","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1074\/jbc.M309660200","article-title":"Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase\/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol","volume":"279","author":"Martin","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/bst0280033","article-title":"The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin","volume":"28","author":"Hayes","year":"2000","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2022.114380_bib9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00044-020-02539-y","article-title":"Nrf2 activation through the inhibition of Keap1\u2013Nrf2 protein\u2013protein interaction","volume":"29","author":"Lee","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2022.114380_bib10","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.redox.2015.07.008","article-title":"Antioxidant responses and cellular adjustments to oxidative stress","volume":"6","author":"Espinosa-Diez","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2022.114380_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2015.05.034","article-title":"Structural basis of Keap1 interactions with Nrf2","volume":"88","author":"Canning","year":"2015","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.ejmech.2022.114380_bib13","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1128\/MCB.24.19.8477-8486.2004","article-title":"The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase","volume":"24","author":"Cullinan","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114380_bib14","doi-asserted-by":"crossref","first-page":"7803","DOI":"10.1074\/jbc.M112.437996","article-title":"Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases","volume":"288","author":"Canning","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib15","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1128\/MCB.23.22.8137-8151.2003","article-title":"Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress","volume":"23","author":"Zhang","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114380_bib16","doi-asserted-by":"crossref","first-page":"11908","DOI":"10.1073\/pnas.172398899","article-title":"Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants","volume":"99","author":"Dinkova-Kostova","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2022.114380_bib17","doi-asserted-by":"crossref","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","article-title":"Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex","volume":"24","author":"Zhang","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114380_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbrc.2013.02.065","article-title":"Diffusion dynamics of the Keap1\u2013Cullin3 interaction in single live cells","volume":"433","author":"Baird","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2022.114380_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/tx700302s","article-title":"Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3","volume":"21","author":"Rachakonda","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2022.114380_bib20","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1128\/MCB.00753-07","article-title":"Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response","volume":"27","author":"Tong","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114380_bib21","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1515\/BC.2006.164","article-title":"Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism","volume":"387","author":"Tong","year":"2006","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.biotechadv.2014.03.004","article-title":"Monitoring Keap1\u2013Nrf2 interactions in single live cells","volume":"32","author":"Baird","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2022.114380_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway","volume":"47","author":"Kensler","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2022.114380_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/MCB.26.1.221-229.2006","article-title":"Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1","volume":"26","author":"Kobayashi","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114380_bib25","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bbamcr.2008.05.024","article-title":"Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motif","volume":"1783","author":"Li","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2022.114380_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.taap.2009.06.009","article-title":"Nrf2 signaling and cell survival","volume":"244","author":"Niture","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114380_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-015-1579-5","article-title":"Redox- and non-redox-metal-induced formation of free radicals and their role in human disease","volume":"90","author":"Valko","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2022.114380_bib28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/med.21257","article-title":"Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents","volume":"32","author":"Magesh","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2022.114380_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.molmed.2011.02.006","article-title":"NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease","volume":"17","author":"Boutten","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2022.114380_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/ars.2008.2242","article-title":"The Nrf2\/ARE pathway as a potential therapeutic target in neurodegenerative disease","volume":"11","author":"Calkins","year":"2008","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2022.114380_bib31","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","article-title":"Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis","volume":"367","author":"Fox","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.114380_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.mrfmmm.2004.05.024","article-title":"Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms","volume":"555","author":"Keum","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2022.114380_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.apsb.2015.05.008","article-title":"Discovery of direct inhibitors of Keap1\u2013Nrf2 protein\u2013protein interaction as potential therapeutic and preventive agents","volume":"5","author":"Abed","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2022.114380_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"365","author":"Pergola","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.114380_bib35","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2022.114380_bib36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/tx100389r","article-title":"Modification of Keap1 cysteine residues by sulforaphane","volume":"24","author":"Hu","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2022.114380_bib37","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"De Zeeuw","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.114380_bib38","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","article-title":"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model","volume":"26","author":"Tong","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114380_bib39","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1021\/acs.jmedchem.8b00358","article-title":"Non-covalent small-molecule Kelch-like ECH-associated protein 1\u2013nuclear factor erythroid 2-related factor 2 (Keap1\u2013Nrf2) inhibitors and their potential for targeting central nervous system diseases","volume":"61","author":"Pallesen","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib40","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1016\/j.bmcl.2013.03.013","article-title":"Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction","volume":"23","author":"Hu","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114380_bib41","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/jm5000529","article-title":"Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis","volume":"57","author":"Jiang","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib42","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1021\/acs.jmedchem.5b00185","article-title":"Structure\u2013activity and structure\u2013property relationship and exploratory in\u00a0vivo evaluation of the nanomolar Keap1\u2013Nrf2 protein\u2013protein interaction inhibitor","volume":"58","author":"Jiang","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib43","doi-asserted-by":"crossref","first-page":"116300","DOI":"10.1016\/j.bmc.2021.116300","article-title":"Optimization of 1,4-bis(arylsulfonamido)naphthalene-N,N'-diacetic acids as inhibitors of Keap1-Nrf2 protein-protein interaction to suppress neuroinflammation","volume":"44","author":"Abed","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib44","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1021\/acs.jmedchem.6b00228","article-title":"Monoacidic inhibitors of the Kelch-like ECH-associated protein 1: nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein\u2013protein interaction with high cell potency identified by fragment-based discovery","volume":"59","author":"Davies","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib45","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/jm4017174","article-title":"Rapid identification of Keap1\u2013Nrf2 small-molecule inhibitors through structure-based virtual screening and Hit-based substructure search","volume":"57","author":"Zhuang","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112734","article-title":"Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions","volume":"207","author":"Lu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib47","doi-asserted-by":"crossref","first-page":"115343","DOI":"10.1016\/j.bmc.2020.115343","article-title":"Discovery of disubstituted xylylene derivatives as small molecule direct inhibitors of Keap1-Nrf2 protein-protein interaction","volume":"28","author":"Abed","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib48","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10822-014-9799-y","article-title":"Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis","volume":"28","author":"Jiang","year":"2014","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2022.114380_bib49","doi-asserted-by":"crossref","first-page":"85983","DOI":"10.1039\/C5RA16262A","article-title":"Binding thermodynamics and kinetics guided optimization of potent Keap1\u2013Nrf2 peptide inhibitors","volume":"5","author":"Lu","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2022.114380_bib50","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1039\/C6MD00500D","article-title":"Small molecules inhibiting Keap1\u2013Nrf2 protein\u2013protein interactions: a novel approach to activate Nrf2 function","volume":"8","author":"Zhuang","year":"2017","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2022.114380_bib51","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2018.02.010","article-title":"Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis","volume":"117","author":"Meng","year":"2018","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.ejmech.2022.114380_bib52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acs.biochem.9b00943","article-title":"Interaction energetics and druggability of the protein\u2013protein interaction between kelch-like ECH-associated protein 1 (KEAP1) and nuclear factor erythroid 2 like 2 (Nrf2)","volume":"59","author":"Zhong","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2022.114380_bib53","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1021\/jm900030h","article-title":"Structurally simple inhibitors of lanosterol 14\u03b1-demethylase are efficacious in a rodent model of acute Chagas disease","volume":"52","author":"Suryadevara","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib54","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1016\/j.tet.2016.07.021","article-title":"Simple and convenient copper-catalyzed amination of aryl halides to primary arylamines using NH4OH","volume":"72","author":"Seon Jung","year":"2016","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2022.114380_bib55","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1021\/ja4056239","article-title":"Silver-mediated trifluoromethylation of aryldiazonium salts: conversion of amino group into trifluoromethyl group","volume":"135","author":"Wang","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114380_bib56","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1016\/j.bmcl.2016.10.083","article-title":"Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity","volume":"26","author":"Yasuda","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114380_bib57","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1021\/jo900600m","article-title":"Copper(I)-catalyzed aryl bromides to form intermolecular and intramolecular carbon\u2212oxygen bonds","volume":"74","author":"Niu","year":"2009","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib58","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1087057111430124","article-title":"Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap1-Nrf2 interaction","volume":"17","author":"Inoyama","year":"2012","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2022.114380_bib59","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/acsmedchemlett.5b00407","article-title":"Polar recognition group study of Keap1-Nrf2 protein\u2013protein interaction inhibitors","volume":"7","author":"Lu","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114380_bib60","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/2472555220935816","article-title":"Development of a homogeneous time-resolved fluorescence resonance energy transfer (TR-FRET) assay for the inhibition of Keap1\u2013Nrf2 protein\u2013protein interaction","volume":"26","author":"Lee","year":"2021","journal-title":"SLAS Discov."},{"key":"10.1016\/j.ejmech.2022.114380_bib61","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2015.08.049","article-title":"Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators","volume":"103","author":"Jain","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib62","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.114380_bib63","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422002823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422002823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:40:53Z","timestamp":1759329653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422002823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":63,"alternative-id":["S0223523422002823"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114380","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationships of 1,4-bis(arylsulfonamido)-benzene or naphthalene-N,N\u2032-diacetic acids with varying C2-substituents as inhibitors of Keap1-Nrf2 protein-protein interaction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114380"}}